These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27477101)

  • 1. Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill.
    Steiner D; Finke JH; Kwade A
    Int J Pharm; 2016 Sep; 511(2):804-13. PubMed ID: 27477101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
    Speer I; Preis M; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instant ODFs - Development of an intermediate, nanoparticle-based product platform for individualized medication.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():149-158. PubMed ID: 28414191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
    Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
    Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on disintegration methods for oral film preparations.
    Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
    Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on novel test systems to determine disintegration time of orodispersible films.
    Preis M; Gronkowsky D; Grytzan D; Breitkreutz J
    J Pharm Pharmacol; 2014 Aug; 66(8):1102-11. PubMed ID: 24673551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
    Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
    Thabet Y; Lunter D; Breitkreutz J
    Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOFTs - Structured orodispersible film templates.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
    Song Q; Guo X; Sun Y; Yang M
    AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films.
    Ṣen Karaman D; Patrignani G; Rosqvist E; Smått JH; Orłowska A; Mustafa R; Preis M; Rosenholm JM
    Eur J Pharm Sci; 2018 Sep; 122():152-159. PubMed ID: 29966736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orodispersible Films for Compounding Pharmacies.
    Ferreira AO; Brandão MAF; Raposo FJ; Polonini HC; Raposo NRB
    Int J Pharm Compd; 2017; 21(6):454-461. PubMed ID: 29220334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Oral Cavity Model for Screening the Disintegration Behavior of Orodispersible Films: A Bespoke Design.
    Redfearn A; Scarpa M; Orlu M; Hanson B
    J Pharm Sci; 2019 May; 108(5):1831-1836. PubMed ID: 30639737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films.
    Janssen EM; Schliephacke R; Breitenbach A; Breitkreutz J
    Int J Pharm; 2013 Jan; 441(1-2):818-25. PubMed ID: 23266759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Material Attributes of Strip Films Loaded With Poorly Water-Soluble Drug Nanoparticles: II. Impact of Polymer Molecular Weight.
    Krull SM; Ammirata J; Bawa S; Li M; Bilgili E; Davé RN
    J Pharm Sci; 2017 Feb; 106(2):619-628. PubMed ID: 27871727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embedding of Poorly Water-Soluble Drugs in Orodispersible Films-Comparison of Five Formulation Strategies.
    Steiner D; Tidau M; Finke JH
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film: preparation, characterization, pharmacokinetic evaluation and its
    Sinha S; Sonali ; Garg V; Thapa S; Singh S; Chauhan M; Dutt R; Singh RP
    Drug Dev Ind Pharm; 2022 Jul; 48(7):279-291. PubMed ID: 35913103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micronized Zaleplon Delivery via Orodispersible Film and Orodispersible Tablets.
    Manda P; Popescu C; Juluri A; Janga K; Kakulamarri PR; Narishetty S; Narasimha Murthy S; Repka MA
    AAPS PharmSciTech; 2018 Apr; 19(3):1358-1366. PubMed ID: 29352403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orodispersible Films: A Systematic Patent Review.
    Gijare C; Deshpande A
    Recent Pat Drug Deliv Formul; 2018; 12(2):110-120. PubMed ID: 29745346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.